Every year, we invest tens of millions of R&D expenses to improve the technology and upgrade the technology. Lvman Bio uses scientific and technological strength to brew sweet business. Not only its products are exported to more than 40 countries and regions around the world, but its annual export sales amount to more than 15 million US dollars, and it has become a leading star enterprise in the natural sweetener industry.

Sweet is a kind of taste. Eating sweets contributes to the secretion of dopamine and can bring people a sense of happiness. In Xiangjiang New District, Hunan, Hunan Lvman Biotechnology Co., Ltd. (hereinafter referred to as "Lvman Bio") is an enterprise that deeply cultivates the sweet cause under the blessing of science and technology. Based on the big health industry, through the research and innovation of plant extracts and natural sweeteners, Lvman Bio has produced natural sweeteners such as mogroside, stevioside and natural compound sugar, which are exported to more than 40 countries and regions around the world, and achieved rapid revenue growth for many years.

Take technology as the guide, reduce costs and increase efficiency to seize the market.

"Technology and talents are crucial to the development of enterprises. Without high-level R&D and investment, our road to entrepreneurship will not be so smooth, and it is impossible to win today’s position in the natural sweetener market." Zhang Baotang, chairman of Lvman Bio, told the reporter that as a high-tech enterprise growing up in the new district, Lvman Bio has always paid attention to technical strength and innovation, and attached importance to cooperation with universities and colleges in Industry-University-Research.

"We work closely with Hunan Agricultural University, Hunan University of Traditional Chinese Medicine and other professional colleges and universities to accurately cultivate the technical talents needed by the company. Lvman Bio is a high-value patent achievement transformation unit of the National Plant Resources Component Utilization Research Center of Academician Liu Zhonghua. Professor Gong Yushun, as a pit stop expert of the model expert workstation of Lvman Bio in Hunan Province, provided technical support for the company’s new product research and development and quality control. " Zhang Baotang said, "Every year, we will invest about 10 million yuan in R&D funds to carry out technological transformation and optimization in seedling optimization, plant extraction and application expansion of natural sweeteners."

The first product of green vine biology is Siraitia grosvenorii extract. Because of the low content of sweet components in fruit and limited by the technology at that time, the cost of extracted mogrosides is higher than that of sucrose, and it is not dominant in the market. However, the green vine keeps optimizing the seedling and upgrading process, reducing the cost and increasing the efficiency from the whole process of planting, production and sales, and finally the production cost of mogroside 50%MV is greatly reduced, which is cheaper than sucrose when converted into sweetness cost performance.

With the advantages of sweetness, purity, color and cost, Siraitia grosvenorii extract and sweet tea extract of green vine quickly seized the market. "Now, our Siraitia grosvenorii extract has a global market share of about 5%, and the sweet tea extract has a global market share of about 60%. The company’s products are exported to more than 40 countries and regions such as Europe, America, Japan and Southeast Asia." Zhang Baotang said proudly.

Taking scientific research as a breakthrough and expanding the territory of sweet career

Into the green vine biological natural sweetener manufacturing center, all kinds of advanced production equipment such as pure water equipment, reverse osmosis membrane equipment, ceramic membrane equipment and continuous countercurrent extraction unit are dazzling. It is also equipped with the most advanced research and development instruments and testing equipment in the domestic extraction industry, such as high performance liquid detection equipment and gas chromatography.

"R&D is endless. In 2016, we began to try the intelligent transformation of production, and it takes about one month to improve and upgrade the equipment and technology every year. " Zhang Baotang revealed that at present, Lvman Bio has its own advanced technology in removing heavy metals, pesticide residues and polycyclic aromatic hydrocarbons, and has applied for more than 70 national invention patents, with 32 authorized invention patents. Among them, the project "Research and Industrialization of Green and Efficient Extraction Technology of Siraitia grosvenorii" has strong technical innovation, ranking the leading level in the same industry in China.

In the green vine, the slogan "One fruit, two leaves, change the sweet cause of mankind" is particularly eye-catching. However, the green vine creatures that started with natural sweeteners did not stop there. "For example, there are not only sweet ingredients in Siraitia grosvenorii, but also other beneficial ingredients. We are studying how to’ squeeze clean’ the value of each Siraitia grosvenorii." Zhang Baotang said with a smile.

Relying on the natural sweetener research institute established by the company, Zhang Baotang led a first-class R&D team including phytochemistry, traditional Chinese medicine, biotechnology and natural medicinal chemistry, and actively participated in R&D work. With their joint efforts, Greenvine has successfully developed more than 240 kinds of standard plant extracts, which can produce as many as 900 kinds of plant extracts, with an annual production capacity of more than 800 tons.

"At present, Lvman Bio has two plant extraction production plants with cGMP (Good Manufacturing Practice for Chinese Herbal Medicine) standards. The second-phase sweetener production project of Hunan Tianman Bio, a wholly-owned subsidiary, is expected to be partially put into production this year. After all the production, our company’s production capacity will be expanded to 5 to 10 times." Zhang Baotang introduced.

With the aim of "serving human health and helping to reduce blood sugar globally", Lvman Bio has completed the whole industrial chain layout of Siraitia grosvenorii and other products from seedlings to dining tables, and is striding forward to become the leading enterprise of natural sweeteners in China.

Welcome to Autohome Wuhan Promotion Channel, today brings you an exciting car purchase news! This high-profile SUV model is currently having a big promotion. In the Wuhan area, you have the opportunity to enjoy a car purchase discount of up to 30,000 yuan, and the minimum starting price is already as low as 209,800 yuan. This is an opportunity not to be missed. If you want to know more details and get higher discounts, just click the "Check the car price" button in the quotation form, let’s seize this car purchase opportunity together.

The Beijing BJ60 shows its unique style with a tough and atmospheric exterior design. The front face is equipped with a large chrome-plated air intake grille, which complements the powerful headlight group, showing a sense of power and luxury. The body lines are smooth and full, and the overall style combines off-road and urban elements, which not only meets the needs of outdoor adventure, but also meets the elegance of urban driving. The contour design on the side of the body highlights the sense of power, and the tail shows a simple and stable shape. The details reflect the unique charm of the BJ60.

The side lines of the Beijing BJ60 are elegantly designed and tough. The body size is 5040mm x 1955mm x 1925mm, and the wheelbase reaches 2820mm, ensuring a spacious interior space. The front and rear wheel tracks are 1620mm and 1640mm respectively, providing excellent stability for the vehicle. The car is equipped with 265/65 R18 tires, and the tire specifications complement the rim style, which not only enhances the driving performance, but also adds to the visual beauty of the vehicle. Overall, the side design of the Beijing BJ60 combines practicality and aesthetics, showing a unique urban off-road style.

The interior design of the Beijing BJ60 focuses on practicality and comfort, and the steering wheel is wrapped in exquisite leather material to provide a good grip. The steering wheel supports manual up and down + front and rear adjustment to meet the individual needs of the driver. The center console is equipped with a large 12.8-inch screen, integrated with automatic speech recognition control system, which brings convenient operation experience to the driver. In terms of seats, whether it is imitation leather material or multi-directional adjustment functions of the main and passenger seats, such as front and rear, backrest, high and low and waist support, are designed to provide ultimate ride comfort. In addition, the front seats are equipped with heating, ventilation and massage functions, as well as power seat memory functions, reflecting Beijing BJ60’s attention to detail and satisfaction of user requests.

The Beijing BJ60 is equipped with a 2.0T engine with a maximum power of 120 kilowatts and a strong torque of 400 Nm. The engine has an output of 163 horsepower, providing ample power support for the vehicle. Matched with an 8-speed automatic transmission, it ensures smoothness and driving pleasure.

Summarizing the evaluation of car owners, Beijing BJ60, with its atmospheric appearance, high-quality interior and strong performance, shows high cost performance at an extremely attractive price of more than 200,000 yuan. The car owner particularly appreciates its quality beyond the same level of models, as well as the various preferential policies enjoyed, such as purchase tax reduction and factory activities, which saved him nearly 20,000 yuan in the car purchase process. In addition, he is also satisfied with the gifts and lifelong basic maintenance services provided by the store. Feng Gongzi emphasized that from the whole to the details, the BJ60 is undoubtedly a golden cost-effective choice, and it is undoubtedly an excellent choice for drivers who love driving.

　　The major revolutionary history drama "Avenue Salary" is being broadcast. The drama tells the history of the revolution from the perspective of economic construction and shows the original mission and struggle of the Chinese Communist Party.

　　The drama was co-produced by the Propaganda Department of the Jiangxi, Shandong and Guizhou Provincial Party Committees. Song Yeming served as the chief director, Zhang Qiang served as the chief screenwriter, and Hou Jingjian, Zhang Bo, Wang Weizhi, and Xu Xiaosa starred. The drama focuses on the economic construction of the Chinese Soviet Republic during the historical period from 1931 to 1935. By reproducing the story of the Chinese Communists punishing corruption, strengthening the construction of education, medical care and other fields, and solving various local people’s livelihood problems, it shows the spiritual quality of the Communists who are not afraid of difficulties, face difficulties, and serve the people wholeheartedly.

　　According to reports, in order to film this drama well, the main creative team went to the scene where the story took place to film, and truly reproduced famous battle scenes such as the Battle of Shuikou, the Battle of Guangchang, and the Battle of Xiangjiang.

　　Reporter: Wang Peng

　　Image provided by the drama

Bao ‘an Daily, August 16, 2019. The weather in Shenzhen recently.It’s hot except hot!From morning heat to night,Leaving the air conditioner is sweating,In fact, the most terrible thing in summer is not the heat!It’s a power outageThe weather has been hot recently,Residents’ electricity consumption has surged,Frequent power outages occurred in some areas of Baoan.Xiaobian field investigation and contact Baoan Power Supply Bureau.

To this question,Relevant staff responded to the recent power outage.

Electricity overload in hot weather

Baoan power supply bureau quick check and reply

Recently, some netizens reported that No.140, Gongle Shangtang, Xixiang, Baoan, had a power outage for two consecutive nights from August 12th to 13th.For this case,Xiaobian learned from Baoan Power Supply Bureau,There are many tenants in the compartment of the residential building in the village.The electric load increases in hot weather,Heavy load operation of transformer leads to over-current and burning of the front line of the meter,After receiving the news,Baoan Power Supply Bureau organized the investigation,Construction personnel timely replace the meter front line to restore power supply.The next day,Due to the substantial increase in electricity loadTransformer branch switch is overloaded and tripped,This led to another power outage in the area of No.140, Shangtang, Gongle.

Baoan Power Supply Bureau:

Arrange personnel for low-voltage load regulation to restore power supply.

In order to ensure the electricity consumption in this area, Baoan Power Supply Bureau has worked out and implemented a load regulation scheme to temporarily alleviate the electricity shortage in this area by checking and sorting out the line load in this area. However, in view of the problem of heavy-load operation of transformers, it is impossible to add transformers because of the shortage of electricity rooms in this area. Only when the community provides electricity rooms for the power supply bureau can the shortage of electricity in this area be completely solved to meet the growth of residents’ load.

Residential buildings turn off power every night.

In fact, the property itself "uses electricity at the wrong peak"

Recently, our citizen hotline received a call from the public, saying that in Xicheng Community of Shajing Street, several buildings have been blacked out in turn every night in recent days, which has caused troubles to residents’ daily electricity consumption.

After verification by Baoan Power Supply Bureau,Xicheng community where citizens live.Non-Baoan power supply bureau meter reading users,Property owner of power supply transformerShenzhen bailihongji investment development co., ltd.The power outage in the community is due toThe property management office of the residential area is worried about the overload of electricity consumption.If the equipment is damaged, "off-peak power consumption" will be carried out by itself.The residential buildings in the whole community only have the phenomenon of power failure in turn.This measure belongs to the self-limiting behavior of the residential property.Non-Bao ‘an Power Supply Bureau’s measures of "off-peak power consumption" and line failure.

Baoan power supply bureau is also interested in transformer property rightsIssue a rectification notice for potential safety hazards in electricity consumption,Ask it to go to the power supply bureau for capacity increase as soon as possible,Eliminate potential safety hazards.

It is understood that according to the relevant regulations, the power supply bureau implements meter reading to households with legal property rights, and then manages power points in compliance. Some unified buildings or houses with small property rights have no legal property rights, so the power supply bureau failed to read the meter to the households, and the transformer property rights party is responsible for the electricity consumption of these users who have not read the meter to the households.

In order to effectively solve the power outage problem,Baoan Power Supply Bureau appealed,Citizens and friends understand and strongly support the construction of power supply facilities.Work together to create a good environment for power supply and use.

The theme of aliens has always been an extremely important part of American science fiction literature and science fiction movies. Interestingly, according to the summary of scholars, the alien images in these sci-fi works have undergone complex changes of the times and generations. For example, aliens in the 1960s and before were often cruel, violent and aggressive, while aliens in the 1970s and 1980s were peaceful and became good friends of human beings.

From fifty years ago to now, what changes have people experienced in the image of aliens in the imaginary world? Why did this change happen?

Aliens before the 1960s

Before the 1960s, the science fiction craze in the United States had just started. During this period, there appeared alien works such as World War, UFO Invasion of the Earth, Invisible Invaders and so on. Generally speaking, the alien images at this time are mostly cruel, militant and irrational.

The movie The War of the Worlds is based on the original novel of the same name by British writer H.G. Wells.

In 1953, The War of the Worlds told us that aliens from Mars could not survive because of the sudden change of climate on Mars, and planned to invade the earth on a large scale. When the first spaceship landed on the earth, nearby residents thought it was a meteorite. Dr. Crawfast learned that there was radioactivity through the detection instrument, and he had to wait until it was cooled before he could see it. However, some people went to watch it out of curiosity, only to be killed. Human weapons could not fight against Martians, and the whole earth was in a mess. At the beginning of the whole film, Martians killed three unarmed young people who shouted "We are friends" and "We welcome you".

Stills of UFO Invasion of the Earth.

In 1956, UFO Invasion of the Earth was about aliens trying to invade the Earth. After encountering aliens, Dr. Lu Se developed a secret weapon of high-frequency ultrasound, which eventually subdued the aliens. It is worth noting that there is also a strong "human imagination" in this film, that is, aliens have human-like limbs, wear clothes similar to humans, and have a similar structure to humans. The only difference is that the aliens’ heads are buns-shaped and have no facial features. Probably because the routine is simple, and the production level of early science fiction films is still rough, on Douban, this film only scored 5.7 points.

Some scholars have analyzed that this image of aliens in this era is inseparable from the outbreak of the Korean War. In the film, human beings are faced with all the weapons that aliens can use, even nuclear weapons. This confrontation actually reflects that Americans demonize their enemies through a cultural product such as movies, and then find reasons for their violent behavior. Anyone in the film who shows the idea of submission or anti-war will be criticized, and the spirit of fighting to the end will be respected.

Aliens in the 1970s and 1980s

Different from the previous era, the aliens in this period were gentle, simple and amiable as a whole, but human beings seemed "inhuman". Representative works include E.T. Alien, Cocoon, Alien Lover and so on.

Alien lovers.

In 1984′ s Alien Lovers, an alien was shot down by the earthlings because of his spaceship. He was injured and went to the widow’s house, and borrowed her husband’s body to continue his life. In the process of learning the life style of the earth people, aliens have feelings with widows. Like many alien science fiction works at this time, "separation" is inevitable, and the alien rescue team will arrive in three days and take him back to space. Two government officials on earth received the message and decided to catch aliens.

E.t. aliens.

This story is almost the same as E.T. Alien, which was released in 1982. The latter is that children in the human world found a little alien who was accidentally lost. He quietly took in the little alien and treated E.T. with the greatest kindness and introduced him to his friends. However, people finally found E.T. and put it in the laboratory, so the friends began a rescue journey.

Most of the aliens in this period came to visit the earth because of accidents, which was different from the previous "weird" ferocity. At this time, the aliens either had a sense of "sprouting" or approached the human image, which was different from that in the 1950 s only from the design of characters. On the contrary, people on earth are extremely unfriendly to aliens because of greed or in the name of "science"

This presentation is also related to the change of American society’s view of war after the Vietnam War, which is very different from the Korean War era. At this time, the people are looking forward to peace in the mainstream. As an "other" image, aliens also turn enemies into friends in movies, and all contradictions are entangled in human beings themselves.

Aliens after the 1990s.

Near the end of the century, the images of aliens in sci-fi works show different patterns, which mainly have two characteristics. One is that some sci-fi movies are different from the mainstream in the previous era, and the thinking of aliens after 1990 is more complicated; The second is that some films have fallen back to before 1960. At this time, representative works such as Contact in Time and Space, Independence Day, Surprise and District 9.

Aliens in "Sky Attack".

In 1996, the movie "Sky Attack" told that the earth suddenly received radio waves from outside the solar system, which made the weather unpredictable everywhere. Scientists began to investigate this phenomenon and found that aliens had settled in a corner of the earth and changed into people on earth. They are trying to change the weather on the earth, and scientists need to stop it from happening. In terms of value orientation, this film actually goes back to before the 1960s, that is, aliens are regarded as enemies.

The aliens in District 9 are a bit like locusts and a bit like shrimps.

In addition, District 9 and The Impersonator all show more complicated aspects. For example, in "District 9" in 2009, the aliens in the film looked like locusts and were extremely ugly. They came to the earth because of the poverty of other planets. The United Nations set up a special "District 9" to take care of them, but with the improvement of physical conditions, they brought a lot of trouble to the local public security, and the government decided to move these aliens to refugee areas. In the film, these aliens are ugly, cruel and decadent, drunk and robbed, but they are also rich in wisdom and know how to repay their kindness, which shows great goodwill to the human beings who help them.

From beginning to end, aliens are regarded as "the other" in the human film world. Aliens will not participate in human life, and even if they turn into human beings to participate in the operation of human society, they will eventually face the problem of "return". Moreover, the design and production of science fiction films are entirely out of human imagination. In this imagination space, whether the "other" of aliens is hostile or peaceful, whether it is revenge or good for evil, it profoundly reflects a country’s imagination of the outside world.

references

Nie Xinru: Cold War Thinking and Alien Construction in American Science Fiction Films (Journal of Shanghai University (Social Science Edition), No.3, 2013).

　　Xing Ziyan (right), a "takeaway operator" who shuttles through Guangzhou Zhujiang New Town every day. Photo by interviewee

　　Putting on a ponytail, wearing T-shirt jeans, sunscreen ice sleeves, and riding a small electric donkey has become the daily standard of Xing Ziyan’s work. Xing Ziyan, 23, is a "food delivery operator". Her daily work is to shuttle through the Pearl River New Town in Guangzhou CBD to help merchants launch food delivery and promote operations.

　　Before graduating from Guangzhou University and joining a food delivery platform two years ago, Xing Ziyan had hardly visited Zhujiang New Town, let alone knew that it was home to the largest number of high-end catering merchants in Guangzhou. From being rejected by catering bosses at first, to being able to analyze takeaway data and help merchants improve their business conditions, Xing Ziyan enjoys this sense of being needed. She said that she has changed from a "foodie" to a professional "foodie".

　　In recent years, our country’s digital economy has continued to develop, and more and more catering merchants have begun to contact and use digital tools, and have launched takeaway services one after another. According to public data, the size of the takeaway market has exceeded 650 billion yuan. Taking Meituan takeaway as an example, as early as 2020, the number of orders completed in a single day has exceeded 40 million yuan. According to previous data from the Guangdong Catering Industry Association, the COVID-19 epidemic has accelerated the process of digitalization of quality restaurants to a certain extent. At present, more than half of five-star hotels and more than 80% of time-honored brands in Guangzhou have launched takeout. The takeaway market is trending well, and more and more catering merchants have followed the trend and touched the Internet, which has also promoted the development process of catering digitalization. At the same time, the demand for takeaway professionals has also risen, and "takeaway operators" have come into being. This once mysterious profession has gradually been recognized and understood by the public.

　　"Actually, it’s quite difficult," Ms. Xing said, adding that many of her friends misunderstood her job and thought it should be easy for her to go shopping, eat, drink and have fun every day. But Ms. Xing, who manages nearly 200 restaurants in Zhujiang New Town, has a lot of work every day. She analyzed that every business district is different, and the customer base for lunch and dinner is also different. There is a lot of knowledge in it, and all of them "run" by themselves.

　　In the beginning, Xing Ziyan often ate "closed doors". Due to the lack of solid professional knowledge and no personal connections, many bosses were reluctant to chat with her. "The biggest difference between Zhujiang New Town and other places is that it is difficult to meet the boss in the restaurant." Xing Ziyan said that for a period of time, she was guarding the door almost every day, just to "squat the boss". "The catering bosses in CBD are not ordinary people, and they need to use their strong professional operation knowledge to convince them that takeout is helpful to them."

　　After adjusting her mindset, Xing Ziyan focused her work on the old merchants who had already settled in. Through visits, operation and promotion, she established a certain customer base relationship with the bosses. After accumulating a certain reputation in the industry, the old merchants gradually began to introduce new merchants to Xing Ziyan.

　　Signing a merchant is only the first step in going online for takeaway, and the bigger problem is the follow-up operation. Xing Ziyan said that as a takeaway operator, you need to pay close attention to the restaurant’s takeaway production. Whether the quality of the ingredients of the merchant passes the customs, whether the packaging is strict or not, and how the service attitude is, even if a detail is not up to standard, it will directly affect the merchant’s order. When encountering merchants who do not have a high order conversion rate, they need to re-build the takeaway menu, and even from offline store decoration to promotion, they must help the merchant optimize and give feedback.

　　During the COVID-19 epidemic, a merchant in Zhujiang New Town launched takeout. At that time, the dishes sold were relatively expensive, and the customer base of takeout was basically regular customers. After Xing Ziyan learned about the situation, she suggested that the merchant take out the signature dish "stir-fried yellow beef" as a single set meal. The staple food is accompanied by rice and vegetables to keep the cost down. The monthly sales of takeout by the merchant suddenly soared from nearly 300 orders to about 1,200 orders.

　　In a western restaurant in the office building, the person in charge of the restaurant opened the data of the online store and asked Xing Ziyan for advice: "During this period of time, we opened a new event on the platform, and I feel that the effect is not very good. Is there something wrong with the setting?" After careful study, Xing Ziyan gave a suggestion, "You can try to match different packages and activities at different times; the order volume every Monday is the lowest, and then it rises all the way, indicating that after the weekend, everyone’s consumption mentality has a recovery process…"

　　A merchant said bluntly, "There are too many takeout doors, and there is no way to start without guidance. Thanks to a’takeaway operator ‘like Xing Ziyan." Seeing that the merchant made money, Xing Ziyan was also very proud, "I think every store here is actually related to me, and they will become better because of my existence."

　　"Takeaway operation is a very deep knowledge, and it has been advancing with the times." Xing Ziyan believes that doing this requires constantly observing the market, whether there are new categories emerging, and which set of operation methods is the most effective. "This is a process of continuous learning and iteration, and after summing up experience, tell the merchant which method is the most effective."

　　In the past two years, Xing Ziyan has helped many mid-to-high-end restaurants that had never thought of serving takeout before to serve takeout, and has also helped many restaurants that have never touched takeout to "start from scratch" and achieve an average of over 1,000 orders per month. She is familiar with every corner of Zhujiang New Town, and can accurately tell the launch time of each restaurant, and even the predecessors of these stores.

　　Sometimes, Xing Ziyan felt that it was hard, especially in winter or summer. However, she quickly convinced herself with the attractiveness of her career that she could freely "go shopping" outside during working hours, buy a cup of milk tea on the road, and chat with different people. This was probably her greatest harvest and happiness.

　　There are more channels for people to understand the catering industry. They will use various platforms to actively find some stores that they have not been to, read other people’s comments, and then try it themselves. Xing Ziyan said that the jobs on these platforms are all new opportunities.

　　Nowadays, ordering "takeout" has become an increasingly dependent way of life, not only in the catering industry, but also in reality, buying vegetables, daily necessities, and even maternal and infant products, as long as you can think of them, there is no delivery. In takeout data, merchants can always capture subtle changes in consumer preferences to improve their business strategies in a timely manner.

　　These days, Xing Ziyan cannot go out to work due to a broken toe, but her phone and mobile phone messages have hardly stopped. She said that this state is the same 365 days a year, and the pressure is much greater than that of e-commerce operations. "The goods of e-commerce are delivered every few days, and the takeaway is delivered immediately, which means that all kinds of problems encountered by merchants are immediate and need to be solved quickly."

　　The emergence of the new profession of "takeaway operator" indicates that the takeaway operation is gradually becoming more professional, which also releases more job opportunities to the local life service field. According to the recruitment platform, in first-tier cities such as Beijing, Shanghai, Guangzhou and Shenzhen, the demand for "takeaway operation" related positions is large, and most positions have a monthly salary of more than 10,000 yuan. In addition to traditional catering practitioners, many fresh graduates, retired military personnel, migrant workers, and people with disabilities have chosen to engage in the new profession of "takeaway operator". According to the "Big Data Report on the Development of China’s Takeaway Industry in 2020", from 2015 to 2019, the market size of China’s catering takeaway industry showed a rapid upward trend, with an average annual compound growth rate of 45.46%. Industry experts believe that the development trend of the takeaway industry has formed a talent siphon effect.

　　In order to enable the new profession of "takeaway operator" to serve the majority of catering merchants more systematically, in May 2020, Meituan Training and Meituan New Catering Research Institute jointly launched the "takeaway operation talent training program" with the Education and Training Center of the Ministry of Human Resources and Social Security. The training provides courses on five core competencies: business understanding, product research & development, platform operation, user operation, and data analytics. Students who successfully pass the course assessment will receive a certificate jointly issued by the Education and Training Center of the Ministry of Human Resources and Social Security and Meituan. This is also the first takeaway operator program in the industry endorsed by government entities.

　　China Youth Daily · China Youth Network reporter, Lin Jie

The large-scale China market has been opened, and the giants of multinational pharmaceutical companies are deploying. China’s innovative drug market has become a battleground for enterprises.

New drugs brought about by the priority review and approval and the accelerated registration of imported drugs have been listed in China, reaching the first small climax in 2017.

In 2017, the number of imported innovative drugs registered in China for the first time reached 39, including 34 chemical drugs and 5 biological drugs. Most of them were approved through the priority review process, and the fastest one took only five months from CDE acceptance to approval.

Moreover, as of the end of January 2018, there are still 20 imported innovative drugs in the review and approval queue, most of which have been included in the priority review and approval. It is expected to be approved in 2018~2019.

From the indication point of view, the treatment fields of these products are all over the popular treatment fields such as tumor, hypertension, diabetes, autoimmune diseases, hepatitis C, pulmonary hypertension, etc. Many products are direct competitors, and most of them are the first heavyweight varieties of the same type in the world. This not only greatly enriches the treatment options of patients, but also forms a competitive mechanism in price and expands the accessibility of drugs.

The huge China market has been opened, and the giants of multinational pharmaceutical companies are in the process of deployment. China’s innovative drug market has become a battleground for enterprises. With the deepening of the reform of drug evaluation system and China’s increasing participation in international multi-center clinical research, the "China time difference" of global new drugs is getting shorter and shorter.

BI, Novartis and Johnson & Johnson are in the first echelon according to the number of products approved by enterprises.

one

China becomes the largest emerging market of BI.

China has become the largest emerging market of BI, with a large number of new drugs that were previously stuck in the approval process being approved one after another.

In 2017, a total of five innovative chemical drugs of BI were approved by CFDA, including two hypoglycemic drugs, namely, O-Tang Jing (Engleggin) and O-shuangning (Liggliptin/Metformin), one antihypertensive drug, Shuangjia (Telmisartan-Amlodipine), and two anticancer drugs, Nidanib (Wigardt) and Afatinib (Gitairui), for the treatment of non-small cell lung cancer.

Among them, the listing of afatinib is of nodal significance. It is the first imported new drug whose "listing application" has been given priority review, and it is also the first imported new drug approved for listing by CFDA with the qualification of "priority review". As the first EGFR-TKI in China, its curative effect is significantly better than that of the first generation. Its listing indicates that the speed of overseas new drugs entering China will be greatly accelerated.

Afatinib was approved by more than 70 countries to treat EGFR mutation positive non-small cell lung cancer before it was approved in China, and it has become the first choice of EGFR targeted drugs in many areas. It was first approved in July 2013 in the United States, and was approved in China after an interval of three years and eight months. Compared with the average interval of five years when international new drugs are approved in China, it is two years ahead of schedule.

In 2016, the global sales of SGLT-2 inhibitor, a new oral hypoglycemic drug, was US$ 4.58 billion, but this kind of drug has just started in China. Dapagliflozin, AstraZeneca’s new diabetes drug approved in March 2017, is the first SGLT-2 inhibitor listed in China. As the second SGLT-2 inhibitor listed in China, Engleggin was listed later than Dapagliflozin. At present, the two products are direct competitors. Among local enterprises, Hengrui, Dongyang Guangyao and Xuanzhu Medicine have already started clinical trials, and Hengrui’s Henggelijing started the Phase III clinical trial in June last year, which lasted for 52 weeks.

Nidanib ethanesulfonate soft capsules for the treatment of specific pulmonary fibrosis (IPF) were accepted by CDE on April 17th, 2017, included in the priority review on June 6th and approved on September 22nd. A total of five months, it can be described as rapid.

The global IPF market will reach US$ 3.2 billion in 2025, and the global sales of Nidanib in the first half of 2017 is 429 million euros (RMB 3.36 billion), which is one of the best performing drugs in that year. There are about 500,000 IPF patients in China, and the number of cases is increasing. Before the approval of Nidanib, the only domestic product to treat IPF was pirfenidone from Roche. At present, both products are expensive. It is worth noting that the new drug Ifinidone for IPF developed by Guangdong Zhongsheng Pharmaceutical Co., Ltd. has been approved for clinical use by CDE.

Undoubtedly, the approval of these products in China will boost the strong growth of BI’s performance in China in the next few years. According to the data, as of January, 2018, BI has two innovative pharmaceutical products, Audat Luo and Tiotropium Bromide, which are under review and approval, and both are in the priority review process.

Both drugs are COPD (chronic obstructive pulmonary disease) drugs. The global and domestic COPD markets are expanding, but there has been a lack of heavy products. Tiotropium bromide has always been the best-selling product of BI, and it is predicted by EvaluatePharma that it is the only drug that may enter the "Top 50 Best-selling Drugs List in 2020" in the field of COPD.

At the same time, in 2018, BI will also develop biopharmaceuticals in China.

In May 2017, BI China Bio-pharmaceutical Base was officially launched in Shanghai Zhangjiang Hi-tech Park, which is the fourth bio-pharmaceutical base of BI after German, Austrian and American, demonstrating its determination to use this base as a "bridge" and quickly enter the bio-pharmaceutical market in China. In the beginning of 2018, BI signed a commercial supply agreement with Baekje Shenzhou on the latter’s research on the PD-1 antibody tislelizumab, which was produced in the biopharmaceutical production base as an exploration of the drug marketing license holder system.

Prior to this, BI has promoted 27 biopharmaceutical products to the global market, and the establishment of the fourth biopharmaceutical base in China will also accelerate the listing of its biopharmaceutical products in China.

2

Novartis: Innovation Drives Growth

Novartis has always been defined as a pharmaceutical company driven by innovation. At present, the impact of the expiration of Gleevec’s patent is being offset by the gradual increase of innovative pharmaceutical products listed later. According to the financial report released by Novartis Group, the net income of Novartis increased by 2% in 2017, among which products such as Cosentyx and Noxintuo grew strongly.

For Novartis, listing more innovative drugs in China is an important link for it to increase the innovative market in China. As early as 10 years ago, Novartis set up a biomedical research center in China, which is also one of its three R&D centers in the world. In the China market, in 2017, Novartis had five products, namely indane Dutrow/glycopyrrolate (Jierun) for treating COPD, shakubit-valsartan (Noxintuo), rucotinib (Jiekewei) and pezotinib (Vequantel), and also included a biological drug, namely omazumab (Zhuole) for treating asthma.

Among them, Shakuibi Trivalsartan is a breakthrough and innovative drug in the treatment of chronic heart failure in the world in recent 20 years. According to reports, Noxintuo has been off the assembly line at Novartis Changping factory at the end of 2017 and officially entered the market.

Lucotinib is currently the only targeted drug approved for the treatment of myelofibrosis in the world. In 2016, Jiekewei’s global sales reached US$ 853 million. Thanks to the expansion of the global bone marrow fibrosis market, Jiekewei also maintained a double-digit growth in 2017H1. At the launch conference of Jiekewei, Novartis said that china charity federation Jiekewei patient assistance project will also be launched during the year to ensure standardized treatment for patients.

Omazumab is the first monoclonal antibody drug in the world and the only one in China to treat asthma. It was first marketed in Australia in 2002, and has been approved for marketing in more than 90 countries around the world, and its indications are gradually expanding. In the past five years, its global sales have steadily increased. In 2016, its global sales reached 2.356 billion US dollars, making it a well-deserved heavy biopharmaceutical.

China is one of the countries with the highest mortality rate of asthma, and the prevalence rate is increasing gradually. There are many kinds of asthma treatments listed in China, but most drugs still can’t control the symptoms of patients. As the first targeted drug, omazumab will open a new chapter in the treatment of allergic asthma. If the price is reasonable, it will be rapidly released in China market. However, Novartis is also facing competitors. Among local enterprises, omazumab biological analogues from Zhangjiang Biological and other enterprises have entered clinical phase III.

Sertinib, the second-generation ALK inhibitor under review and approval, was approved by FDA as the first-line therapy for ALK+ non-small cell lung cancer in 2017. It is expected to join the priority review and approval queue in the future.

three

Johnson & Johnson: Two Heavy Biological Drugs Entering China

In 2017, Johnson & Johnson listed the leukemia drug Ibotinib (Yike), the hepatitis C drug cimetivir (Olesen) and the new type 2 diabetes drug Carglinide (Yikean) in China.

With a strong research and development pipeline for autoimmune diseases, Johnson & Johnson has also listed two biopharmaceuticals in China, namely Gorimumab for treating ankylosing spondylitis and Usinotuzumab for treating psoriasis. It is also full of harvest.

Golimumab is the first approved anti-rheumatic TNF preparation injected subcutaneously once a month in China, and it is also one of the top ten anti-rheumatic drugs in the world. In the global market, the global sales of golimumab have been rising all the way. In 2016, it sold $1.745 billion, ranking 36th in the top-selling drug top50 list in 2016.

The indication of Gorimumab approved in China is ankylosing spondylitis, but in the world, four indications have been approved. With more indications approved in China, it will compete for market share with imported TNF inhibitors such as Hummel, Leike and Enli, and domestic TNF inhibitors such as Yisaipu, Qiangke and Anbainuo.

The current market of TNF inhibitors in China is about 1.5 billion yuan, and the potential market exceeds 10 billion yuan. Domestic Yisaipu occupies more than 60% market share with price advantage. In the new national medical insurance catalogue in 2017, the recombinant human tumor necrosis factor receptor-antibody fusion protein was included in the national medical insurance category B for the first time, which will expand the TNF inhibitor market as a whole and help to increase the volume of golimumab, but the pricing problem still needs to be considered.

Usinotuzumab is a classic standard drug for psoriasis, benefiting from the overall rapid expansion of the autoimmune disease drug market, which rose by 24% in 2017 and exceeded $4 billion for the first time.

four

Multinational pharmaceutical giants are leading the way.

In 2017, the number of new drug approvals in the second echelon was AstraZeneca (3), AbbVie (2), BMS(2) and Bayer (2).

Amritsar from AstraZeneca was approved for the treatment of type 2 diabetes, and it was a competitor with Ou Shuangning from BI. The listing of Teresa, a third-generation targeted drug for non-small cell lung cancer, created the fastest record of less than one month from approval to marketing, and in just a few months, it had already sold $23 million in China, and soon after approval, it was included in the scope of serious illness medical insurance in Zhejiang Province.

Abvir is a joint listing of two antiviral treatment schemes for hepatitis C, Obipali tablets and Dasebvir sodium tablets, which is called "3D scheme". It is used to treat adult chronic hepatitis C with genotype 1, and the course of treatment can be as short as 12 weeks. It took only 6.5 months from listing to approval, and 2 months from approval to listing. At present, patients in Shanghai, Beijing and Zhejiang have enjoyed the drug. It is reported that another heavy hepatitis C pan-gene product of AbbVie has been approved for listing in the United States, the European Union and Japan, and the course of treatment has been shortened to 8 weeks. In the future, AbbVie will promote the listing of this innovative drug in China.

In September 2017, Gilead’s hepatitis C drug sofebuvir was also approved for listing by CFDA. So far, in the field of direct oral anti-hepatitis C virus (DAA) treatment, there has been a situation of direct competition among four multinational pharmaceutical companies, namely cimetivir from Johnson & Johnson, daratavir+Ashurivir from BMS, Obpari+Dasebuvir Sodium Tablets from Abbey and Sofibuvir from Gilead. In local enterprises, Geli’s Dannuo Ruiwei is also listed soon, and a number of enterprises are eyeing it. It can be seen that the competition in this field is fierce.

Among the 20 imported innovative drugs to be approved in the future, navuzumab from BMS is worthy of attention. This is the first PD-1/PD-L1 monoclonal antibody approved for marketing in the world, and the first PD-1/PD-L1 monoclonal antibody applied in China when it was submitted. It has been approved for 9 indications in the United States.

Levatinib from Weicai Company has been approved for the treatment of refractory thyroid cancer in more than 50 countries or regions, and it has been approved for the second-line treatment of renal cell carcinoma in more than 40 countries in combination with everolimus. The indication for this application in China is hepatocellular carcinoma.

There is also Amgen’s world’s first CGRP monoclonal antibody Eloizumab injection, which is used to prevent migraine. Some analysts predict that it can achieve annual sales of up to $12.5 billion worldwide. Olapali from AstraZeneca is the first PARP inhibitor listed in the world, and Lydiparvid/Sorobupvir from Gilead is a daily compound single-chip cocktail therapy … …

Part of the data in this paper comes from GBI Health report "Summary of New Drug Evaluation in 2017" by Deng Gaifang.

Christmas in the United States was suddenly a thrilling scene.

On the busiest travel day before Christmas, American Airlines suddenly grounded all flights. On December 24th, local time, the Federal Aviation Administration (FAA) suddenly announced that American Airlines had grounded all flights nationwide.

Subsequently, American Airlines quickly issued a statement, pointing out that all its flights were facing technical difficulties, and promised to go all out to resume flight operations in the shortest time. Affected by this, American Airlines once fell more than 5% before the market.

At around 21: 00 Beijing time, the Federal Aviation Administration said that the grounding measures for American airlines had been cancelled. American Airlines said that the short grounding was attributed to the failure of the technology supplier, and the grounding measures lasted for about an hour. After the opening of the US stock market, the share price of American Airlines fell, once falling more than 2% in intraday trading.

Suddenly grounded

On December 24th, local time, the Federal Aviation Administration (FAA) announced in a statement that American Airlines had grounded all flights nationwide. But no reason was given.

Subsequently, American Airlines posted on social platform X that all its flights were experiencing technical problems, which led to the interruption of operations on one of the busiest travel days of the year.

The post also added: "Your safety is our top priority. Once the problem is solved, we will let you reach your destination safely." In response to questions from other social media users, the airline said it could not estimate how long the repair would take.

American Airlines said that the specific repair schedule has not yet been determined, but the team is making every effort to solve the current technical problems as soon as possible.

In a statement to ABC, American Airlines added: "We are making every effort to solve this problem quickly and sincerely apologize for the inconvenience caused to passengers."

American Airlines operates thousands of flights every day to more than 350 destinations in more than 60 countries.

Some online posts reflect that the airline cannot accurately calculate the weight and balance demand of flights due to software failure. The airline said in another post that it is working hard to repair it, but it is not sure how long it will take.

Affected by this, American Airlines once fell more than 5% before the market.

At around 21: 00 Beijing time, the Federal Aviation Administration announced that it had cancelled the grounding order for American airlines. American Airlines said that the short grounding was attributed to the failure of the technology supplier, and the grounding measures lasted for about an hour.

After the opening of the US stock market, the share price of American Airlines fell, once falling more than 2% in intraday trading.

According to the data of the US Transportation Security Administration, nearly 40 million passengers are expected to be inspected from December 19th to January 2nd, 2025, which is 6.2% higher than the same period in 2023, reflecting the continuous recovery of air travel demand in the United States.

According to Reuters, a few months ago, American Airlines was grounded due to global technical failures related to Microsoft’s Azure cloud platform and software problems of network security company CrowdStrike. Two years ago, Southwest Airlines crashed during the holidays, resulting in the cancellation of 16,900 flights and 2 million passengers stranded. The company was finally fined $140 million, which is the highest civil fine ever imposed due to the interruption of travel.

The recovery of American aviation industry

Recently, the share price of American Airlines has continued to strengthen, stimulated by the recovery of the aviation industry. According to the latest data, since August this year, the share price of American Airlines has risen by more than 90%, which shows the market’s confidence in its performance and industry recovery.

In the news, Wall Street analysts are generally optimistic about airline stocks, which is attributed to the economic recovery, the sharp increase in demand, the increase in fares and the improvement in cost management.

According to the data released by the Transportation Security Administration (TSA), on December 1, local time, the passenger flow at American airports reached 3,087,392, a record high.

At the same time, American Airlines recently raised its profit forecast for the last few months of this year, and it is expected that its performance will be even stronger in the key holiday travel season.

American Airlines said in a regulatory document that it expects adjusted earnings per share to reach 55 cents to 75 cents in the fourth quarter, compared with 50 cents at most. The revised range easily exceeded analysts’ average expectation of 40 cents.

In addition, due to the strong demand for travel at the end of the year, JetBlue also updated its guidelines for the fourth quarter. The airline expects that the revenue in the fourth quarter will drop by 2% to 5%, compared with the previous forecast of 3% to 7%; The number of available seat miles is expected to drop by 4.5% to 6.5%, compared with the previous forecast of 4% to 7%.

According to Morgan Stanley’s research, the demand for business travel is expected to return to 85% before the epidemic in 2024. Business travelers are usually willing to pay higher fares, which makes a significant contribution to airline profits. In addition, the increasing demand for luxury and long-distance travel has further enhanced the attractiveness of airlines’ high-end products.

Recently, several airlines have received "buy" ratings from Wall Street analysts. Among them, Goldman Sachs raised the target price of American Airlines by 15% on the grounds of revenue growth and improved financial situation. Morgan Stanley believes that the aviation industry is in the initial stage of structural recovery, and it is expected to usher in stable growth in the next few years, raising the target share price of American Airlines Group from $18 to $22, and maintaining the "overweight" rating.

In addition, airlines also give back to shareholders by buying back shares and paying dividends. For example, Delta Air Lines plans to buy back $2 billion worth of shares in the next two years, which shows its confidence in future cash flow.

In addition to the recovery of traditional markets, the growth potential of aviation demand in emerging markets is equally huge. According to IATA’s forecast, by 2035, the number of air passengers in the Asia-Pacific region will reach 3.5 billion, accounting for nearly 50% of the global total. Among them, China and Indian aviation markets are becoming the main sources of growth for international airlines.

Proofreading: Liu Xingying

　　Cctv newsAccording to the latest data released by the Japan Institute of Real Estate Economics in September, the sales volume of new residential buildings in the Japanese metropolitan area increased by 7% year-on-year in August, achieving growth for two consecutive months. Among them, the sales volume of real estate in downtown Tokyo once increased by 40%.

　uptown

　　This is a residential area in the center of Tokyo. This 100-family house is nearing completion. According to the developer, the first phase has been sold out.

　　Since the Bank of Japan implemented the monetary easing policy four years ago, the price of new residential buildings in the Japanese capital circle has continued to rise. In the first half of this year, the average price of each set hit a new high in 26 years after Japan’s real estate bubble burst in the 1990s. At present, the average price of three bedrooms and one living room of about 70 square meters is about 65.62 million yen, or about 3.88 million yuan.

　　According to the developer, as the main force of buying a house, most dual-employee parenting families prefer houses with complete facilities near the station. For the convenience of their old age, wealthy elderly couples have a strong demand for changing houses in the downtown area with convenient transportation.

　　It is estimated that the annual sales volume of new residential buildings in the capital circle is expected to increase by 6.2% year-on-year this year, reaching 38,000 sets.

　　The property market in the capital circle is hot, but in many local cities in Japan, there is a surplus of houses and housing prices are shrinking. The land price trends announced by Japan’s Ministry of Land, Infrastructure, Transport and Tourism this month show that the three metropolitan areas of Tokyo, Osaka and Nagoya remain unchanged, while other local cities have fallen by 1%.

　　Beijing, January 20 (Reporter Li Jinlei) Recently, some media reported that supplementary medical insurance and enterprise annuity were added on the basis of "five insurances and one gold", which became "six insurances and two gold". In fact, supplementary medical insurance and enterprise annuity (a kind of supplementary old-age insurance) are paid voluntarily, not compulsorily. Moreover, supplementary medical insurance and enterprise annuity have existed for a long time, but the newly promulgated Enterprise Annuity Measures came into effect on February 1 this year. Don’t get me wrong.

　　"Five insurances and one fund" include endowment insurance, medical insurance, maternity insurance, unemployment insurance, industrial injury insurance and housing accumulation fund.

　　Recently, some media reported that on the basis of "five insurances and one gold", supplementary medical insurance and enterprise annuity were added, which became "six insurances and two gold".

　　In this regard, many netizens mistakenly believe that these are two new treatments added by the state for employees, which enterprises must force to pay to employees. However, in fact, supplementary medical insurance and enterprise annuity are established voluntarily, and they have existed for a long time, which is not new.

　　Let’s talk about supplementary medical insurance first, which is a supplementary form of basic medical insurance compared with basic medical insurance. According to data from the Ministry of Human Resources and Social Security, by the end of 2016, there were 290.22 million employees participating in supplementary medical insurance nationwide.

　　Zhang Yinghua, an executive researcher at the World Social Security Research Center of China Academy of Social Sciences, told the reporter of Zhongxin.com that supplementary medical insurance is a welfare added by the unit (employer) for employees, which is generally a commercial insurance purchased by the group. In 1998, the Decision of the State Council on Establishing the Basic Medical Insurance System for Urban Employees stipulated that the supplementary medical insurance premium of enterprises within 4% of the total salary shall be paid from the employee welfare fund.

　　Zhang Yinghua explained that there is no uniform regulation on whether the supplementary medical insurance is paid by individuals, and it varies from place to place. It can be paid by the enterprise, or it can be paid jointly by the unit and the individual, and withheld and remitted by the unit.

　　The reporter found that taking Beijing as an example, as early as 2001, Beijing promulgated the Interim Measures for Supplementary Medical Insurance for Enterprises in Beijing, proposing that "enterprises participating in the basic medical insurance in this city can establish supplementary medical insurance for their employees and retirees (foreign-invested enterprises are limited to Chinese employees)".

　　Note that the method says "yes", not compulsory and compulsory payment. According to the measures, the supplementary medical insurance of enterprises is mainly used to solve the medical expenses borne by retirees and the medical expenses that employees need to pay for hospitalization.

　　It is understood that at present, the threshold for medical insurance for employees in Beijing is 1,800 yuan, that is to say, from January 1 to December 31 of each year, 1,800 yuan must be spent, and the part exceeding 1,800 yuan can be reimbursed; Anything less than 1800 yuan is paid by oneself.

　　In other words, if you spent less than 1800 yuan on medical insurance in that year, it was not enough for reimbursement. At this time, supplementary medical insurance came in handy.

　　Let’s talk about enterprise annuity again. Enterprise annuity is also called occupational annuity. It is a supplementary pension insurance system independently established by enterprises and their employees through collective consultation on the basis of participating in basic pension insurance according to law. It is an important part of the second pillar of China’s multi-level pension insurance system.

　　In short, the enterprise annuity is a supplementary pension insurance. Employees participating in the enterprise annuity is conducive to adding a pension accumulation on the basis of the basic pension insurance, and further improving the income level and quality of life after retirement.

　　It should be noted that the state encourages enterprises to establish enterprise annuities, but it is not mandatory.

　　Moreover, enterprise annuities have been around for many years. On January 6, 2004, the former Ministry of Labor and Social Security issued the Trial Measures for Enterprise Annuity. By the end of 2016, 76,000 enterprises had established enterprise annuities nationwide, with 23.25 million employees and accumulated funds of 1.1 trillion yuan.

　　In other words, enterprise annuity is an old system that has been implemented for more than ten years. However, since February 1, 2018, the newly formulated Enterprise Annuity Measures will be officially implemented. The "Measures for Enterprise Annuity" issued this time is a revision and improvement of the "Trial Measures for Enterprise Annuity" in 2004.

　　According to the regulations, the expenses required for enterprise annuities are jointly paid by enterprises and individual employees. The enterprise payment shall not exceed 8% of the total wages of the employees of the enterprise every year.

　　When it comes to enterprise annuities, many people say that they are unfamiliar. This is because, compared with pension insurance, the penetration rate of enterprise annuities is not high. In 2016, the number of people participating in national pension insurance was 887.77 million, while the number of employees participating in enterprise annuities was only 23.25 million.

　　As for the low penetration rate of enterprise annuity, Zhang Yinghua said that this is mainly because enterprise annuity is voluntary, and many enterprises, especially small and medium-sized enterprises, have no motivation and ability to participate.

　　In addition, Zhang Yinghua said that the "Enterprise Annuity Measures" stipulates that three conditions must be met when launching an enterprise annuity plan: participating in basic old-age insurance and fulfilling payment obligations, having corresponding economic affordability, and establishing a collective negotiation mechanism. These three conditions must be met at the same time. For many private enterprises, small and medium-sized enterprises and collective enterprises, it is difficult to meet at the same time, and the principle of voluntary establishment is adopted, and the employee mobility is high, so the participation rate is not high. (End)